We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current LBPH market cap is 2.34B. The company's latest EPS is USD -1.3938 and P/E is -43.03.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.64M | -13.58M | -15.57M | -18.11M | -25.64M |
| Net Income | -15M | -12.93M | -15.03M | -14.99M | -21.79M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -14.4M | -27.84M | -44.8M | -56.76M |
| Net Income | -14.4M | -27.8M | -43.95M | -54.42M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 66.22M | 58.86M | 50.7M | 327.67M | 312.91M |
| Total Liabilities | 8.12M | 6.82M | 9.77M | 13.96M | 18.31M |
| Total Equity | 58.11M | 52.04M | 40.92M | 313.71M | 294.6M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 56.24M | 108.95M | 70.62M | 50.7M |
| Total Liabilities | 3.14M | 5.63M | 9.15M | 9.77M |
| Total Equity | -2.69M | 103.32M | 61.47M | 40.92M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -26.55M | -39.84M | -50.87M | -15.18M | -34.31M |
| Investing | 14.05M | 25.79M | 24.23M | -230.92M | -251.61M |
| Financing | 21.24M | 27.18M | 30.19M | 286.4M | 286.43M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.44M | -24.71M | -38.06M | -50.87M |
| Investing | N/A | -40.72M | -17.06M | 24.23M |
| Financing | 58.76M | 76.45M | -444k | 30.19M |
| Market Cap | 2.34B |
| Price to Earnings Ratio | -43.03 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 163.43 |
| Price to Book Ratio | 57.23 |
| Dividend Yield | - |
| Shares Outstanding | 39.05M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 36.43k |
| 52 Week Change | 843.08% |
| 52 Week High | 60.03 |
| 52 Week Low | 5.97 |
| Spread (Intraday) | -6.01 (-10.55%) |
| Company Name | Longboard Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.longboardpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
